Sinovac laboratory in China developing coronavirus vaccine

The video provides an inside look at Sinovac, a biotech company in Beijing, working on a COVID-19 vaccine. It covers the vaccine's development, production, and clinical trials, highlighting its potential to protect against the virus. The vaccine is in stage two human trials, with production ramping up to 100 million doses. Challenges include low COVID-19 cases in China, prompting global testing. Sinovac recommends prioritizing high-risk groups for vaccination. The video emphasizes the importance of a vaccine in overcoming the pandemic.

What is the significance of the results published in the journal Science?

Who are the primary targets for the vaccine according to the recommendations?